SCCM Resource Library-Effect of Early Nasal High-Flow for Children With Acute Hypoxemic Respiratory Failure: The PARIS-2 Randomized Clinical Trial (JAMA)

Effect of Early Nasal High-Flow for Children With Acute Hypoxemic Respiratory Failure: The PARIS-2 Randomized Clinical Trial (JAMA)

Back to course

Video Transcription

Video Summary

The speaker presents the results of a study on the use of nasal high flow in children with acute hypoxemic respiratory failure. The study was conducted in pediatric hospitals in Australia and New Zealand and included over 1,500 patients. The primary outcome was length of stay in the hospital, but no significant difference was found between the nasal high flow group and the standard oxygen therapy group. There were also no significant differences in secondary outcomes such as ICU admissions and intubations. The speaker suggests that further research is needed to determine the best use of nasal high flow in pediatric patients.

Asset Subtitle

Pediatrics, Pulmonary, 2023

Asset Caption

Type: plenary | Plenary: Late Breaking Studies That Will Change Your Practice (SessionID 9000002)

Meta Tag

Content Type Presentation

Knowledge Area Pediatrics

Knowledge Area Pulmonary

Membership Level Professional

Membership Level Select

Tag Respiratory Failure

Tag Pediatrics

Year 2023

Keywords

nasal high flow

pediatric hospitals

acute hypoxemic respiratory failure

length of stay

further research

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.